Published in Gut on July 31, 2008
Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol (2010) 5.87
Hepatocellular carcinoma: clinical frontiers and perspectives. Gut (2014) 5.79
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol (2011) 3.36
Gene-expression signature of vascular invasion in hepatocellular carcinoma. J Hepatol (2011) 2.39
Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med (2012) 1.71
The indications for liver biopsy. Dtsch Arztebl Int (2012) 1.60
Epidemiology and management of hepatocellular carcinoma. Infect Dis Clin North Am (2010) 1.58
Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination. HPB (Oxford) (2011) 1.54
Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma. J Nucl Med (2014) 1.52
Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing. Liver Transpl (2016) 1.49
APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review. Int J Hepatol (2011) 1.24
2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma. Gut Liver (2015) 1.23
Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed cases. Indian J Dermatol (2011) 1.21
2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma. Korean J Radiol (2015) 1.14
Guide for diagnosis and treatment of hepatocellular carcinoma. World J Hepatol (2015) 1.11
Hepatocellular carcinoma: natural history, current management, and emerging tools. Biologics (2012) 1.10
Treatment and clinical outcome of needle-track seeding from hepatocellular carcinoma. Korean J Hepatol (2011) 1.08
Prognostic factors for hepatocellular carcinoma recurrence. World J Gastroenterol (2014) 1.06
Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china. Liver Cancer (2013) 1.05
A diagnostic paradigm for resectable liver lesions: to biopsy or not to biopsy? HPB (Oxford) (2009) 1.05
Diagnostic endoscopic ultrasonography: assessment of safety and prevention of complications. World J Gastroenterol (2012) 1.01
Diagnostic imaging and biopsy use among elderly medicare beneficiaries with hepatocellular carcinoma. J Oncol Pract (2011) 0.98
Management of hepatocellular carcinoma. J Cancer Res Clin Oncol (2014) 0.96
Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome. World J Hepatol (2015) 0.96
In vivo magnetic resonance spectroscopy of liver tumors and metastases. World J Gastroenterol (2011) 0.90
Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma. Liver Transpl (2011) 0.90
Fine-needle aspiration biopsy of hepatocellular carcinoma and related hepatocellular nodular lesions in cirrhosis: controversies, challenges, and expectations. Patholog Res Int (2011) 0.89
Multimodal treatment of hepatocellular carcinoma on cirrhosis: an update. World J Gastroenterol (2013) 0.89
Noninvasive diagnosis of hepatocellular carcinoma in cirrhotic liver: current guidelines and future prospects for radiological imaging. Liver Cancer (2012) 0.88
Needle track seeding following percutaneous procedures for hepatocellular carcinoma. World J Hepatol (2009) 0.85
Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles. Mol Imaging (2011) 0.84
Clinical utility of acoustic radiation force impulse imaging for identification of malignant liver lesions: a meta-analysis. Eur Radiol (2012) 0.83
Sonographically guided puncture of the pancreas: incidence of complications, and risk factors. J Med Ultrason (2001) (2012) 0.83
Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues. Korean J Radiol (2016) 0.83
How grim is hepatocellular carcinoma? Ann Med Surg (Lond) (2014) 0.83
Liver transplantation for hepatocellular carcinoma: role of inflammatory and immunological state on recurrence and prognosis. World J Gastroenterol (2013) 0.83
Tumour seeding after percutaneous cryoablation for hepatocellular carcinoma. World J Gastroenterol (2012) 0.83
The role of interventional radiology in the management of hepatocellular carcinoma. Curr Oncol (2014) 0.82
Liver Transplantation for HCC: A Review. Indian J Surg (2011) 0.82
Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation. World J Hepatol (2015) 0.82
Role of endoscopic ultrasonography in the evaluation of extrahepatic cholangiocarcinoma. Endosc Ultrasound (2013) 0.81
Nodule in Liver: Investigations, Differential Diagnosis and Follow-up. J Clin Exp Hepatol (2014) 0.81
Hepatocellular Carcinoma: Current Concepts in Diagnosis, Staging and Treatment. Gastrointest Tumors (2014) 0.81
Coincidental occurrence of hepatocellular carcinoma and cholangiocarcinoma (collision tumors) after liver transplantation: a case report. Hepat Mon (2012) 0.81
Needle-track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut (2009) 0.80
A case of IgG4-related hepatic inflammatory pseudotumor replaced by an abscess after steroid treatment. BMC Gastroenterol (2016) 0.80
Pre-treatment double- or triple-positive tumor markers are predictive of a poor outcome for patients undergoing radiofrequency ablation for hepatocellular carcinoma. Surg Today (2016) 0.79
Pre-liver transplant biopsy in hepatocellular carcinoma: a potential criterion for exclusion from transplantation? HPB (Oxford) (2012) 0.79
Hepatic incidentaloma: the rule of tens. HPB (Oxford) (2012) 0.79
Familial hepatocellular carcinoma in an endemic area: two case reports. BMC Res Notes (2015) 0.79
Hepatocellular carcinoma and other malignancies in autoimmune hepatitis. Dig Dis Sci (2013) 0.79
Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis. Eur Radiol (2015) 0.78
Tissue diagnosis of hepatocellular carcinoma. J Clin Exp Hepatol (2014) 0.78
Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future. World J Hepatol (2016) 0.78
Seeding of the rectus sheath with hepatocellular carcinoma after image guided percutaneous liver biopsy using coaxial biopsy needle system. J Radiol Case Rep (2015) 0.77
Pleural tumor seeding following percutaneous cryoablation of hepatocellular carcinoma. Semin Intervent Radiol (2011) 0.77
Clinical implications of basic research in hepatocellular carcinoma. J Hepatol (2015) 0.76
A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma. Surg Today (2016) 0.76
Intraoperative core needle biopsy under complete video-assisted thoracic surgery for indeterminate tumor of lung. Surg Endosc (2015) 0.76
Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma. World J Gastroenterol (2014) 0.76
Living donor liver transplantation with abdominal wall reconstruction for hepatocellular carcinoma with needle track seeding. World J Transplant (2015) 0.76
Liquid Biopsies for Assessing Metastatic Melanoma Progression. Crit Rev Oncog (2016) 0.75
Percutaneous interventional procedures in an era of liver transplantation. Korean J Hepatol (2011) 0.75
Cirrhosis-related musculoskeletal disease: radiological review. Br J Radiol (2016) 0.75
Comprehensive Comparison of Multiple-Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis. PLoS One (2016) 0.75
Ectopic Spleen Tissue - an Underestimated Differential Diagnosis of a Hypervascularised Liver Tumour. Viszeralmedizin (2015) 0.75
Role of FNAC in Hepatic lesions: Risk of track metastases. South Asian J Cancer (2015) 0.75
Risk of seeding is reduced by associating diagnostic biopsy with percutaneous ablation for hepatocellular carcinoma. Gut (2009) 0.75
Liver transplantation for advanced hepatocellular carcinoma. Clin Mol Hepatol (2016) 0.75
Hepatic steatosis and fibrosis: Non-invasive assessment. World J Gastroenterol (2016) 0.75
Response to Braillon. Am J Gastroenterol (2015) 0.75
Surveillance of Hepatocellular Carcinoma and Diagnostic Algorithms in Patients with Liver Cirrhosis. Visc Med (2016) 0.75
Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge. J Hepatocell Carcinoma (2017) 0.75
Dilation of malignant strictures in endoscopic ultrasound staging of esophageal cancer and metastatic spread of disease. Diagn Ther Endosc (2011) 0.75
Surveillance and Diagnosis of Hepatocellular Carcinoma. Gastroenterol Hepatol (N Y) (2015) 0.75
Hepatocellular carcinoma with disseminated skeletal muscle metastasis. Acta Radiol Open (2017) 0.75
The value of feedback in teaching interviewing skills to medical students. Psychol Med (1978) 3.24
Ras signaling is required for serum-induced hyphal differentiation in Candida albicans. J Bacteriol (1999) 3.09
Teaching critical appraisal skills in health care settings. Cochrane Database Syst Rev (2001) 2.57
A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer. Br J Cancer (2002) 2.53
TIP41 interacts with TAP42 and negatively regulates the TOR signaling pathway. Mol Cell (2001) 2.18
Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription. J Cell Sci (2000) 2.08
Erythropoietin or darbepoetin for patients with cancer. Cochrane Database Syst Rev (2006) 2.06
Abuse of indigenous psilocybin mushrooms: a new fashion and some psychiatric complications. Br J Psychiatry (1978) 2.03
Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J Clin Invest (1999) 1.91
The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia (2012) 1.89
Barriers to help seeking in people with urinary symptoms. Fam Pract (2001) 1.81
Systematic review of the psychological consequences of false-positive screening mammograms. Health Technol Assess (2013) 1.81
Diabetic control after total pancreatectomy. Dig Liver Dis (2006) 1.76
Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol (2007) 1.72
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev (2007) 1.68
Liver resection for colorectal metastases. Ann R Coll Surg Engl (2003) 1.66
Treatment of hydatid disease of the liver. Evaluation of a UK experience. Dig Surg (2004) 1.65
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
What is the cost of blindness? Br J Ophthalmol (2003) 1.58
Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells. Cell Death Dis (2010) 1.55
Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK. Eur J Surg Oncol (2005) 1.49
Hydatid liver disease as a cause of recurrent pancreatitis. J R Coll Surg Edinb (1999) 1.49
[Effects of Radix angelicae sinensis on systemic and portal hemodynamics in cirrhotics with portal hypertension]. Zhonghua Nei Ke Za Zhi (1996) 1.49
Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev (2005) 1.47
Riluzole for motor neurone disease. More trials are needed. BMJ (2001) 1.47
A new MALDI-TOF based mini-sequencing assay for genotyping of SNPS. Nucleic Acids Res (2000) 1.46
The type and quality of randomized controlled trials (RCTs) published in UK public health journals. J Public Health Med (1995) 1.46
Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation. Health Technol Assess (2003) 1.46
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Haemorrhage following pancreaticoduodenectomy: risk factors and the importance of sentinel bleed. Dig Surg (2006) 1.37
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model. Health Technol Assess (2012) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Emphysematous cystitis and pyelitis in a diabetic renal transplant recipient. Transplantation (1996) 1.26
Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technol Assess (2000) 1.24
A motif in human histidyl-tRNA synthetase which is shared among several aminoacyl-tRNA synthetases is a coiled-coil that is essential for enzymatic activity and contains the major autoantigenic epitope. J Biol Chem (1994) 1.22
Crystal structure of the nuclear matrix targeting signal of the transcription factor acute myelogenous leukemia-1/polyoma enhancer-binding protein 2alphaB/core binding factor alpha2. J Biol Chem (1999) 1.22
Earliest presence of humans in northeast Asia. Nature (2001) 1.21
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Targeting of the YY1 transcription factor to the nucleolus and the nuclear matrix in situ: the C-terminus is a principal determinant for nuclear trafficking. J Cell Biochem (1998) 1.19
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment. Health Technol Assess (2007) 1.19
Platelet transfusion prophylaxis for patients with haematological malignancies: where to now? Br J Haematol (2005) 1.17
A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence. Health Technol Assess (2010) 1.15
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review. Health Technol Assess (2001) 1.13
Favourable prognostic factors in a large UK experience of adenocarcinoma of the head of the pancreas and periampullary region. Dig Surg (2004) 1.11
Intraatrial extension of thyroid cancer: technique and results of a radical surgical approach. Surgery (1990) 1.11
Outcome of liver resection and transplantation for fibrolamellar hepatocellular carcinoma. Transpl Int (2000) 1.10
Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer. Int J Cancer (2000) 1.09
Pneumatosis cystoides intestinalis (PCI). Int J Colorectal Dis (1990) 1.09
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Specialist outreach service for on-table repair of iatrogenic bile duct injuries--a new kind of 'travelling surgeon'. Ann R Coll Surg Engl (2008) 1.06
Liver transplantation for alcoholic liver disease: evaluation of a selection protocol. Hepatology (1997) 1.05
Differential expression of platelet-derived growth factor-alpha receptor by Thy-1(-) and Thy-1(+) lung fibroblasts. Am J Physiol (1999) 1.05
Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev (2004) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Neuroendocrine tumours of the pancreas: predictors of survival after surgical treatment. Dig Surg (2005) 1.04
The use of liver grafts from donors with bacterial meningitis. Transplantation (2001) 1.03
The effectiveness and cost-effectiveness of parent training/education programmes for the treatment of conduct disorder, including oppositional defiant disorder, in children. Health Technol Assess (2005) 1.03
Hepatocellular carcinoma. Ann Oncol (2001) 1.03
Effect of preoperative chemotherapy on liver resection for colorectal liver metastases. Eur J Surg Oncol (2007) 1.02
Cervical screening programmes: can automation help? Evidence from systematic reviews, an economic analysis and a simulation modelling exercise applied to the UK. Health Technol Assess (2005) 0.99
Water on the sun. Science (1995) 0.99
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Who uses the Cochrane Pregnancy and Childbirth Database? BMJ (1995) 0.98
Use of poly(tetrafluoroethylene)s as a sample support for the MALDI-TOF analysis of DNA and proteins. Anal Chem (1999) 0.96
Transabdominal extensive oesophagogastric devascularization with gastro-oesophageal stapling in the management of acute variceal bleeding. Br J Surg (1997) 0.96
Iron-dependent regulation of ferritin and transferrin receptor expression by the iron-responsive element binding protein. Annu Rev Nutr (1992) 0.96
Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105. Microsc Res Tech (2001) 0.96
PEA3/ETV4-related transcription factors coupled with active ERK signalling are associated with poor prognosis in gastric adenocarcinoma. Br J Cancer (2011) 0.95
Appraisal of compliance with the UICC/AJCC staging system in the staging of gastric cancer. Union Internacional Contra la Cancrum/American Joint Committee on Cancer. Br J Surg (2002) 0.95
Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review. Health Technol Assess (2010) 0.95
Use of paraffin wax film in MALDI-TOF analysis of DNA. Anal Chem (1998) 0.95
Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review. Health Technol Assess (2000) 0.94
Critical appraisal workshops to promote evidence-based healthcare. J Obstet Gynaecol (2000) 0.92
Surgical treatment of metastases to the pancreas. Surgeon (2005) 0.92
A 10-year experience of complex liver trauma. Br J Surg (2002) 0.92
Percutaneous portal vein thrombolysis and endovascular stent for management of posttransplant portal venous conduit thrombosis. Transplantation (2000) 0.91
Receptor crosstalk: reprogramming B cell receptor signalling to an alternate pathway results in expression and secretion of the autoimmunity-associated cytokine, osteopontin. J Intern Med (2009) 0.90
Near-patient tests in primary care: setting the standards for evaluation. J Health Serv Res Policy (2000) 0.90
Techniques for and outcome of liver transplantation in neonates and infants weighing up to 5 kilograms. J Pediatr Surg (2002) 0.90
Risk factors for litigation following major transectional bile duct injury sustained at laparoscopic cholecystectomy. World J Surg (2010) 0.89
Inhibition of tumor growth and induction of apoptosis in prostate cancer cell lines by overexpression of tissue inhibitor of matrix metalloproteinase-3. Cancer Gene Ther (2009) 0.88